All news

Actuate Therapeutics to sell 50 million shares at $0.819

Alpha Vantage · scanx.trade · · AI-summarised by FinFlash

Actuate Therapeutics Inc. plans to sell 50,000,000 shares of its common stock at an assumed public offering price of $0.819 per share, as detailed in a recent SEC filing. The company has not yet finalized the exact terms or net proceeds, and the assumed price is subject to change. This offering will impact existing shareholders' equity value.

Read original source

ACTU company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.